The
report analyzes and presents an overview of " Glioblastoma
Multiforme (GBM) Global Clinical Trials Review, H2, 2016 "
worldwide.
GlobalData's
clinical trial report, Glioblastoma
Multiforme (GBM)
Global Clinical Trials Review, H2, 2016" provides an overview of
Glioblastoma Multiforme (GBM) clinical trials scenario. This report
provides top line data relating to the clinical trials on
Glioblastoma Multiforme (GBM). Report includes an overview of trial
numbers and their average enrollment in top countries conducted
across the globe. The report offers coverage of disease clinical
trials by region, country (G7 & E7), phase, trial status, end
points status and sponsor type. Report also provides prominent drugs
for in-progress trials (based on number of ongoing trials).
GlobalData Clinical Trial Reports are generated using GlobalDatas
proprietary database - Pharma eTrack Clinical trials database.
Clinical trials are collated from 80+ different clinical trial
registries, conferences, journals, news etc across the globe.
Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download
Sample copy of this Report @
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Table of Contents
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top
Five Countries Contributing to Clinical Trials in Europe 10
Top
Countries Contributing to Clinical Trials in North America 11
Top
Five Countries Contributing to Clinical Trials in Middle East and
Africa 12
Top
Five Countries Contributing to Clinical Trials in Central and South
America 13
Clinical
Trials by G7 Countries: Proportion of Glioblastoma Multiforme (GBM)
to Oncology Clinical Trials 14
Clinical
Trials by Phase in G7 Countries 15
Clinical
Trials in G7 Countries by Trial Status 16
Clinical
Trials by E7 Countries: Proportion of Glioblastoma Multiforme (GBM)
to Oncology Clinical Trials 17
Clinical
Trials by Phase in E7 Countries 18
Clinical
Trials in E7 Countries by Trial Status 19
Clinical
Trials by Phase 20
In
Progress Trials by Phase 21
Clinical
Trials by Trial Status 22
Clinical
Trials by End Point Status 23
Subjects
Recruited Over a Period of Time 24
Clinical
Trials by Sponsor Type 25
Prominent
Sponsors 26
Top
Companies Participating in Glioblastoma Multiforme (GBM) Therapeutics
Clinical Trials 27
Prominent
Drugs 28
Latest
Clinical Trials News on Glioblastoma Multiforme (GBM) 29
Aug
04, 2016: DNAtrix Awarded FDA Orphan Products Development Grant for
DNX-2401 29
Jul
25, 2016: ImmunoCellular Therapeutics Provides Update on Lead Cancer
Immunotherapy ICT-107 29
Jul
15, 2016: ZIOPHARM Issues Statement Regarding Phase I Study of Gene
Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer 30
Jul
12, 2016: VAXIMM initiates Phase 1 translational study in
glioblastoma with oral T-cell immunotherapy, VXM01 30
Jun
28, 2016: New Data Suggests Improved Tumor Response For The
Combination of AZIXA and Immune Checkpoint Inhibitors in The
Treatment of Cancer 31
Jun
07, 2016: ImmunoCellular Therapeutics Treats First Patient in ICT-107
Phase 3 Registrational Trial in Newly Diagnosed Glioblastoma 31
Jun
06, 2016: CytRx Presents Updated Aldoxorubicin Clinical Trial Results
at the 2016 American Society of Clinical Oncology Annual Meeting 32
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment